Cargando…

rhIGF-1 Therapy: A Silver Bullet for Bronchopulmonary Dysplasia Prevention?

Detalles Bibliográficos
Autores principales:	Plosa, Erin J., Benjamin, John T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2020
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193858/ https://www.ncbi.nlm.nih.gov/pubmed/32109132 http://dx.doi.org/10.1164/rccm.202002-0287ED

Ejemplares similares

rhIGF-1/BP3 Preserves Lung Growth and Prevents Pulmonary Hypertension in Experimental Bronchopulmonary Dysplasia
por: Seedorf, Gregory, et al.
Publicado: (2020)

The role of rhIGF-1/BP3 in the prevention of pulmonary hypertension in bronchopulmonary dysplasia and its underlying mechanism
por: Qu, Sehua, et al.
Publicado: (2023)

Pilot dose-ranging of rhIGF-1/rhIGFBP-3 in a preterm lamb model of evolving bronchopulmonary dysplasia
por: Albertine, Kurt H., et al.
Publicado: (2023)

Effectiveness and safety of rhIGF1 therapy in patients with or without Laron syndrome
por: Bang, Peter, et al.
Publicado: (2020)

Assessment of compatibility of rhIGF-1/rhIGFBP-3 with neonatal intravenous medications
por: Salamat-Miller, Nazila, et al.
Publicado: (2022)

rhIGF-1 Therapy for Growth Failure and IGF-1 Deficiency in Congenital Disorder of Glycosylation Ia (PMM2 Deficiency)
por: Miller, Bradley S., et al.
Publicado: (2013)

rhIGF-1/rhIGFBP-3 in Preterm Infants: A Phase 2 Randomized Controlled Trial
por: Ley, David, et al.
Publicado: (2018)

Expression of Recombinant Human Insulin-like Growth Factor Type 1 (rhIGF-1) in Escherichia coli
por: Iranpoor, Hamidreza, et al.
Publicado: (2015)

Subcutaneous administration of rhIGF-I post irradiation exposure enhances hematopoietic recovery and survival in BALB/c mice
por: Chen, Shilei, et al.
Publicado: (2012)

Randomized Control Trial of Postnatal rhIGF-1/rhIGFBP-3 Replacement in Preterm Infants: Post-hoc Analysis of Its Effect on Brain Injury
por: Horsch, Sandra, et al.
Publicado: (2020)

Is Silver the Ultimate Antimicrobial Bullet?
por: Turner, Raymond J
Publicado: (2018)

Drug therapy for the prevention and treatment of bronchopulmonary dysplasia
por: Iyengar, Anjali, et al.
Publicado: (2015)

Strategies to improve outcomes of bronchopulmonary dysplasia
por: Jung, Young Hwa, et al.
Publicado: (2019)

Revisiting the Role for HIF Stabilizers in Bronchopulmonary Dysplasia
por: Boucherat, Olivier, et al.
Publicado: (2020)

The Wnt Signaling Pathway and the Development of Bronchopulmonary Dysplasia
por: Lingappan, Krithika, et al.
Publicado: (2020)

Disease Phenotyping of Infants with Severe Bronchopulmonary Dysplasia
por: Mandell, Erica, et al.
Publicado: (2020)

Bronchopulmonary Dysplasia: Endothelial Cells in the Driver’s Seat
por: Vohwinkel, Christine U., et al.
Publicado: (2021)

Preempting Bronchopulmonary Dysplasia: Time to Focus on the Placenta?
por: Thébaud, Bernard
Publicado: (2021)

Can biomarkers be used to predict bronchopulmonary dysplasia?()
por: Bhandari, Vineet, et al.
Publicado: (2020)

Leveraging Microbial Symbiosis to Modulate Bronchopulmonary Dysplasia
por: Peterson, Laura S., et al.
Publicado: (2022)

Radiation Biomarkers: Silver Bullet, or Wild Goose Chase?
por: Rutten, Eric Andreas, et al.
Publicado: (2021)

Mesenchymal Stromal Cell Extracellular Vesicles: A New Approach for Preventing Bronchopulmonary Dysplasia?
por: Klinger, James R., et al.
Publicado: (2022)

An Update on the Prevention and Management of Bronchopulmonary Dysplasia
por: Hennelly, Marissa, et al.
Publicado: (2021)

Low postnatal serum IGF-I levels are associated with bronchopulmonary dysplasia (BPD)
por: Löfqvist, Chatarina, et al.
Publicado: (2012)

D-dimer measurement in COVID-19: Silver bullet or clinical distraction?
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Early Detection of Pulmonary Vascular Dysfunction in Neonatal Bronchopulmonary Dysplasia
por: Hassoun, Paul M.
Publicado: (2020)

NOVEL BIOMARKERS OF BRONCHOPULMONARY DYSPLASIA AND BRONCHOPULMONARY DYSPLASIA-ASSOCIATED PULMONARY HYPERTENSION
por: Sahni, Mitali, et al.
Publicado: (2020)

Lung function in adults born prematurely with bronchopulmonary dysplasia
por: Chen, I-Ling, et al.
Publicado: (2020)

Drug Therapy Trials for the Prevention of Bronchopulmonary Dysplasia: Current and Future Targets
por: Bhandari, Vineet
Publicado: (2014)

Bronchopulmonary Dysplasia: A Continuum of Lung Disease from the Fetus to the Adult
por: Jobe, Alan H., et al.
Publicado: (2019)

Phenotypes of Bronchopulmonary Dysplasia
por: Wang, Shih-Hsin, et al.
Publicado: (2020)

Current Pharmacologic Approaches for Prevention and Treatment of Bronchopulmonary Dysplasia
por: Tropea, Kristen, et al.
Publicado: (2012)

The efficacy and safety of Montelukast sodium in the prevention of bronchopulmonary dysplasia
por: Kim, Sang Bum, et al.
Publicado: (2015)

Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies
por: Principi, Nicola, et al.
Publicado: (2018)

Respiratory support strategies in the prevention and treatment of bronchopulmonary dysplasia
por: Hysinger, Erik B., et al.
Publicado: (2023)

Role of Postnatal Corticosteroids in the Treatment or Prevention of Bronchopulmonary Dysplasia
por: Bulbul, Ali, et al.
Publicado: (2023)

DDR1 Deficiency in Mice: A Spontaneous Model of Bronchopulmonary Dysplasia-associated Pulmonary Hypertension?
por: Çataltepe, Sule, et al.
Publicado: (2022)

Surrogate endpoints in global health research: still searching for killer apps and silver bullets?
por: Pai, Madhukar, et al.
Publicado: (2018)

Mesenchymal Cells and Bronchopulmonary Dysplasia: New Insights about the Dark Side of Oxygen
por: Popova, Antonia P.
Publicado: (2019)

New Imaging Tools Allow Bronchopulmonary Dysplasia to Enter the Age of Precision Medicine
por: Shepherd, Edward G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_409rtvpp84il8v707el2flm95j